Cryoablation with drug-loaded bead embolization in the treatment of unresectable hepatocellular carcinoma: safety and efficacy analysis

Oncotarget
Jian-Ying ZengJian-Guo Liu

Abstract

This study aimed to explore the efficacy and safety of drug-eluting bead (DEB) embolization (DEB-TACE) when combined with cryoablation in the treatment of unresectable hepatocellular carcinoma (HCC). The study was a single-center randomized controlled trial comprised of 60 patients with HCC conducted between August 2015 and October 2017. The patients were randomly divided into two groups: DEB-TACE combined with cryoablation (DEB-TACE-Cryo group) or cryoablation alone (Cryo group). Inter-group differences in overall survival, progression-free survival, and adverse reactions were assessed. The operative success rates were 82.7% and 77.4% in the DEB-TACE-Cryo group and Cryo group, respectively, with no operative mortality. The overall survival and progression-free survival in the DEB-TACE-Cryo group were significantly higher than those in the Cryo group (16.8 months vs.13.4 months,P= 0.0493; 8.1 months vs. 6.0 months,P= 0.0089, respectively). The postoperative complications in the two groups were rated as grade 1 or grade 2, according to guidelines set by the National Cancer Institute Common Terminology Criteria for Adverse Events Version 4.0 (CTCAE V4.0). We demonstrated that DEB-TACE combined with cryoablation was effective, wel...Continue Reading

References

May 3, 2002·Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract·Pierre-Alain ClavienPaul V Suhocki
Dec 10, 2002·Journal of Vascular and Interventional Radiology : JVIR·Koichiro YamakadoKan Takeda
Jun 18, 2005·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Morris Sherman
Feb 1, 2008·Cardiovascular and Interventional Radiology·Antonio OrlacchioGiovanni Simonetti
Aug 5, 2009·World Journal of Gastroenterology : WJG·Ke-Cheng XuJian-Sheng Zuo
Mar 5, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jordi BruixUNKNOWN American Association for the Study of Liver Diseases
May 31, 2011·International Journal of Radiation Oncology, Biology, Physics·Sang Min YoonDong Jin Suh
Jan 14, 2012·Clinical & Developmental Immunology·Sebastian P HaenCécile Gouttefangeas
Dec 28, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Zhen-Wei PengWan Yee Lau
Nov 23, 2013·Cardiovascular and Interventional Radiology·Katerina MalagariDimitrios A Kelekis
Apr 30, 2014·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Zhenyin LiuRijie Tang
Jun 18, 2014·British Journal of Cancer·R GolfieriUNKNOWN PRECISION ITALIA STUDY GROUP
Feb 6, 2015·CA: a Cancer Journal for Clinicians·Lindsey A TorreAhmedin Jemal
Sep 4, 2015·Journal of Gastroenterology and Hepatology·Antonio FacciorussoVincenzo Mazzaferro
Mar 12, 2016·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·Antonio FacciorussoNicola Muscatiello
Oct 19, 2016·Journal of Digestive Diseases·Jing Huai ZouSheng Long Ye
Nov 22, 2016·World Journal of Gastrointestinal Pharmacology and Therapeutics·Antonio FacciorussoNicola Muscatiello
Dec 31, 2016·Oncotarget·Jun-Hui SunShu-Sen Zheng
Jan 14, 2017·Clinical and Molecular Hepatology·Kyoung Doo Song
Jun 22, 2017·Minimally Invasive Therapy & Allied Technologies : MITAT : Official Journal of the Society for Minimally Invasive Therapy·Charles Edouard ZurstrassenRubens Chojniak

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy

Clinical Trials Mentioned

NCT02545556

Software Mentioned

GraphPad

Related Concepts

Related Feeds

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.